Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT04295291 |
Other study ID # |
AB 3418 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
January 1, 2025 |
Est. completion date |
December 31, 2025 |
Study information
Verified date |
April 2024 |
Source |
Ostfold University College |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
The survival after intrahospital cardiac arrest has been reported to 15%. In Norway this
varies between 16 and 23%.). Many factors are associated with survival after cardiac arrest,
both intra- and prehospital. Recent studies have not included information about individual
patient factors and the outcome after cardiopulmonary resuscitation (CPR). In the current
hospital, we are able to record patient specific information related to a cardiac arrest/CPR
situation, and thereby be able to assess patient-related factors associated with both
detection, treatment and outcome of CPR.
Description:
Several factors have been associated with survival, e.g. to monitor hands-off time(Odds
ratio, OR, for 2.48, 95% KI 1.11-5.56, p=.03), monthly assessment of all cardiac arrest cases
(OR 6.9, 95% KI 1.41-33.92), and includin av local coordinator for CPR (OR 2.93, 95% KI
1.08-7.94, p=.03), as well as depth of compressions. Nevertheless, information about cardiac
arrests and CPR have not been assessed in relation to patient specific information. In the
current hospital, we are able to record the CPR sequence, and see this in relation to other
patient- and case- specific information such as initial cardiac rythm, time to first
compression, hands-off time, quality of CPR, and factors affecting the treatment and outcome.
The hospital has 71 registered defibrillators used in CPR. The current study will both gather
retrospective data- not seen in relation to patient specific information, and prospective
data related to specific patients.